Concepedia

Oclacitinib in feline nonflea‐, nonfood‐induced hypersensitivity dermatitis: results of a small prospective pilot study of client‐owned cats

Christian Ortalda, Chiara Noli, Sílvia Colombo, Stefano Borio

Veterinary Dermatology · 2015 · 52 citations · 7 references

DOI

Abstract

Oclacitinib at 0.4-0.6 mg/kg p.o. may be an effective and safe drug for some cats with nonflea-, nonfood-induced hypersensitivity dermatitis. Further studies are needed to identify the most effective dose range for this species.

References

7

Development of an owner‐assessed scale to measure the severity of pruritus in dogs

Peter Hill, Pok Lam Marvin Lau, J. Rybníček · Veterinary Dermatology · 2007 · 232 citations

Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis

Sallie B. Cosgrove, J. A. WREN, Dawn M. Cleaver et al. · Veterinary Dermatology · 2013 · 125 citations · Full text

Establishment of diagnostic criteria for feline nonflea‐induced hypersensitivity dermatitis

Claude Favrot, Jean Steffan, Wolfgang Seewald et al. · Veterinary Dermatology · 2011 · 77 citations

, , +15

The efficacy of cyclosporine A in cats with presumed atopic dermatitis: A double blind, randomised prednisolone-controlled study

M. A. Wisselink, Ton Willemse · The Veterinary Journal · 2008 · 53 citations

, , +9

The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog

Wendy T. Collard, Bernard D. Hummel, A. F. Fielder et al. · Journal of Veterinary Pharmacology and Therapeutics · 2013 · 50 citations